Fundación Eduardo Anitua
Quick facts
Phase 3 pipeline
- Blood clot and simple suture · Surgery/Wound Healing
This is a biological hemostatic product that combines blood clotting factors with a suture material to promote wound healing and hemostasis.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Fundación Eduardo Anitua
What is Fundación Eduardo Anitua's pipeline?
Fundación Eduardo Anitua has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Blood clot and simple suture.
Related
- Sector hub: All tracked pharma companies